Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Zapping nasal nerves could stop runny noses

NCT ID NCT06598319

Symptom relief Sponsor: Aventix Medical Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a device called NOVOCLEAR™ that uses pulsed energy to treat chronic rhinitis, a condition causing long-term runny nose, congestion, itching, and sneezing. The treatment targets nerves in the nose to reduce symptoms. Researchers will enroll 30 adults who haven't gotten enough relief from nasal steroid sprays. The main goal is to see if symptoms improve 90 days after the procedure and to check for any side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
NOVOCLEAR™ Device (pulsed field ablation device)
What this could lead to
If it works, this could offer a new, non-drug option for people with chronic rhinitis that doesn't respond to nasal steroids.
What could go wrong
This is a small, early-stage study with only 30 people, so results may not apply to everyone. The procedure carries risks like any medical device treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. The subject is 18 to 85 years of age. 2. The subject has had symptoms of chronic rhinitis for greater than 6 months with insufficient response to nasal steroids. 3. The subject has an rTNSS total score of ≥ 6. 4. The subject has had moderate to severe symptoms of rhinorrhea and/or nasal congestion (rTNSS rating of 2 or 3 for rhinorrhea and 1, 2, or 3 for congestion) 5. The subject is able and willing to provide written informed consent and comply with the protocol requirements. Exclusion Criteria: 1. The subject has clinically significant anatomic obstructions on either side that limit access to the posterior nose, including severe septal deviation, nasal polyps, and sinonasal tumor 2. The subject has a septal perforation 3. The subject has had prior sinus or nasal surgery on either side that significantly alters the anatomy of the posterior nose. 4. The subject had had previous surgery of the PNN for chronic rhinitis. 5. The subject has had prior head or neck irradiation 6. The subject has an active or chronic nasal or sinus infection 7. The subject has active coagulation disorder, or the patient is receiving anticoagulants 8. The subject has a history of dry eye or dry nose symptoms 9. Patient has rhinitis medicamentosa 10. The subject has ocular allergic symptoms 11. The subject has a history of nose bleeds 12. The subject has electrically sensitive implants (e.g. cochlear implants, pacemakers, defibrillators) 13. The subject is pregnant or lactating 14. The subject is participating in another clinical research study 15. The subject has an allergy or intolerance to anesthetic agent 16. Any physical condition that, in the Investigator's opinion, would prevent adequate study participation or pose an increased risk

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic rhinitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic rhinitis rhinitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic rhinitis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    3 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Atkins Expert Sinus Care

    RECRUITING

    San Antonio, Texas, 78256, United States

  • Bay Area ENT

    RECRUITING

    Ocean Springs, Mississippi, 39564, United States

  • Colorado ENT and Allergy

    RECRUITING

    Colorado Springs, Colorado, 80923, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.